This review examined whether cognitive behavior therapy (CBT)—a talking therapy that helps address thought patterns and behaviors—might help patients with long COVID who experience brain fog, fatigue, and mood problems. The authors compared long COVID to ME/CFS, noting they share many features, and found that while CBT may help some patients feel less tired and think more clearly, it works best when tailored to each person's energy limits and combined with other treatments. Importantly, the authors stress that suggesting CBT does not mean these illnesses are 'all in your head'—they have real physical causes.
Why It Matters
For ME/CFS patients, this review is significant because it clarifies how psychological interventions like CBT should be carefully adapted for conditions with documented biological pathology, not applied as if the illness is primarily psychological. The comparison between long COVID and ME/CFS helps validate ME/CFS experiences and supports the growing recognition of shared mechanisms. This work provides evidence-based guidance for how any psychological support should be integrated thoughtfully into comprehensive, individualized care plans.
Observed Findings
ME/CFS and long COVID share overlapping pathophysiological mechanisms including immune dysregulation, neuroinflammation, and metabolic dysfunction.
Moderate-certainty evidence indicates CBT may reduce fatigue and improve cognitive function in long COVID patients when appropriately implemented.
Clinical trials show methodological evolution from traditional CBT protocols to digital platform delivery, with varied intervention characteristics and outcome measures.
Substantial heterogeneity exists in condition definitions, intervention delivery, and study designs across the literature.
Implementation success requires provider competency in energy management strategies and careful monitoring for post-exertional symptom exacerbation.
Inferred Conclusions
ME/CFS may represent a severe phenotype within a broader long COVID spectrum, sharing core pathophysiological mechanisms while differing in disease trajectory.
CBT, when individualized and combined with comprehensive care (energy management, symptom-specific interventions, comorbidity management), may contribute to outcomes but is not a primary treatment.
Standardized terminology, stronger trial methodology incorporating objective biomarkers, and provider training in illness-specific adaptations are necessary to optimize CBT implementation.
Remaining Questions
Which specific patient subgroups or symptom phenotypes respond best to CBT versus other interventions, and what predictors identify responders?
What This Study Does Not Prove
This review does not prove that CBT cures or reverses ME/CFS or long COVID, nor does it establish that these conditions are primarily psychiatric or psychological in origin. It does not demonstrate which specific CBT components work best or identify patient subgroups most likely to benefit. The review also does not prove causation between any proposed mechanisms (immune dysregulation, neuroinflammation) and symptom improvement from CBT.